Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
COVID-19
100%
Lymphocytes
100%
COVID-19 Patients
100%
Immune Dysregulation
100%
Clinical Determinants
100%
Lymphopenia
75%
Corticosteroids
25%
ISARIC
25%
Corticosteroid Use
25%
Joint Modeling
25%
Immunomodulatory
12%
Disease Progression
12%
SARS-CoV-2 Infection
12%
Prognostic Value
12%
Significant Predictors
12%
Poor Prognosis
12%
Outcome Prediction
12%
Cox Model
12%
In-hospital Mortality
12%
Hospitalization
12%
Hospitalized Patients
12%
Large Population
12%
Transition Rates
12%
Survival Analysis
12%
Cox Regression
12%
Evolution over Time
12%
Multiple Linear Regression
12%
Sepsis
12%
Survivors
12%
Clinical Characterization
12%
Lymphocyte Count
12%
Adjunctive Therapy
12%
ICU Admission
12%
Models & Modelling
12%
28-day Mortality
12%
Viral Infection
12%
Daily Transitions
12%
Multistate Model
12%
Multistate Modeling
12%
Bad Outcomes
12%
Characterization Protocols
12%
Absolute Lymphocyte Count
12%
Temporal Behavior
12%
Time-dependent Covariates
12%
Immune State
12%
Severity Prognosis
12%
Non-survivors
12%
Prospective Observational Cohort Study
12%
Lymphocyte Recovery
12%
Organ Support
12%
Corticosteroid Exposure
12%
Linear Regression Modeling
12%
Hospitalized Adults
12%
Sepsis Pathophysiology
12%
Immunology and Microbiology
Lymphocyte
100%
COVID-19
100%
Immune Dysregulation
100%
Lymphocytopenia
66%
Lymphocyte Count
22%
Infectious Disease
11%
Hospital Mortality
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Infection
11%
Virus Infection
11%